Questionnaire measuring the extent to which AYA NA-SB can be successfully used in cancer programs. Score ranges from 1 to 5 with higher score denoting higher feasibility.
| Group | Value | 95% CI |
|---|---|---|
| Treatment Arm | 4.52 | ± 0.50 |
Last reviewed · How we verify
Improving Care Coordination for Adolescents and Young Adults With Cancer
NA trial testing AYA NA-SB Questionnaire in Cancer in 26 participants. Completed in 26 August 2022.
| Lead sponsor | Wake Forest University Health Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 26 |
| Start date | 15 June 2021 |
| Primary completion | 26 August 2022 |
| Estimated completion | 26 August 2022 |
| Sites | 1 location across United States |
Wake Forest University Health Sciences
Adults 18 to 39, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Questionnaire measuring the extent to which AYA NA-SB can be successfully used in cancer programs. Score ranges from 1 to 5 with higher score denoting higher feasibility.
| Group | Value | 95% CI |
|---|---|---|
| Treatment Arm | 4.52 | ± 0.50 |
Questionnaire measuring perception of whether AYA-NA-SB is agreeable, palatable, or satisfactory to users. Score ranges from 1 to 5 with a higher score denoting higher acceptability.
| Group | Value | 95% CI |
|---|---|---|
| Treatment Arm | 4.5 | ± 0.5 |
Questionnaire measuring perception of AYA-NA-SB's fit, relevance, or compatibility with the context in which it will be used. Score ranges from 1 to 5 with a higher score denoting higher appropriateness
| Group | Value | 95% CI |
|---|---|---|
| Treatment Arm | 4.4 | ± 0.489 |
Care coordination will be assessed by the proportion of Adolescents and Young Adults (AYAs) who reported needs who received services from across disciplines to address reported needs within one month of needs assessment completion.
| Group | Value | 95% CI |
|---|---|---|
| Treatment Arm | 13 |
Questionnaire assessing, among AYAs who reported needs and reported receiving follow-up care, AYAs' perception of the degree to which their needs were adequately addressed during the study period. Scores range from 1 to 5 where higher scores denote that needs were met.
| Group | Value | 95% CI |
|---|---|---|
| Treatment Arm | 3.7 | ± 1.6 |
Average number of needs reported by AYAs.
| Group | Value | 95% CI |
|---|---|---|
| Treatment Arm | 13 | 2 – 21 |
The purpose of this research is to test an intervention designed to identify cancer needs and connect patients with services that address those needs. Participation in this research will involve completing 2 online surveys over the course of 1 month; each should take about 15 minutes to complete.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04586127.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing